Showing 2111-2120 of 3763 results for "".
Lidocaine Shortage: Perspectives, Alternatives, and Pathways Forward
https://practicaldermatology.com/topics/practice-management/lidocaine-shortage-perspectives-alternatives-and-pathways-forward/23949/Supply chain issues, communication barriers, and regulatory inconsistencies cause problems for practitioners and patients.Hair Today
https://practicaldermatology.com/topics/hair-nails/hair-today/23818/Hairapy haircare line boosts volume, fullness in just 3 months.Therapeutics Focus: Psoriasis
https://practicaldermatology.com/topics/psoriasis/therapeutics-focus-psoriasis/20902/Getting to the Root of ACD
https://practicaldermatology.com/topics/atopic-dermatitis/getting-to-the-root-of-acd/20356/A practical approach to dermatitis in young and old.Real-Life Treatment Strategies: Topical Combination Therapy for Plaque Psoriasis in Patients With Skin of Color
https://practicaldermatology.com/topics/psoriasis/real-life-treatment-strategies-topical-combination-therapy-for-plaque-psoriasis-in-patients-with-skin-of-color/21213/Management of psoriasis among individuals with skin of color will become increasingly important for medical professionals. Here's a review of the distinguishing features of psoriasis in patients with skin of color and their treatment needs.Evaluation of Cosmetic Training in Dermatology Residency
https://practicaldermatology.com/youngmd-connect/resident-resource-center/evaluation-of-cosmetic-training-in-dermatology-residency/23670/Survey findings highlight the need to expand cosmetic training in US residency programs.Digital Innovation to the Rescue: The Future of Electronic Prior Authorization in Dermatology
https://practicaldermatology.com/topics/practice-management/digital-innovation-to-the-rescue-the-future-of-electronic-prior-authorization-in-dermatology/20467/Adopting new technology to reduce paperwork, costs, and burnout as well as improve patient care.New Products
https://practicaldermatology.com/columns/new-products/new-products/21337/Selecting the Optimal JAK Inhibitor for Alopecia Areata
https://practicaldermatology.com/topics/hair-nails/selecting-the-optimal-jak-inhibitor-for-alopecia-areata/67265/Since 2022, the US Food and Drug Administration (FDA) has approved three oral JAK inhibitors: baricitinib, ritlecitinib, and deuruxolitinib.Biologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.